Q3 2020 Holdings
Filed 2020-11-16 | 81 holdings | $822.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $259.5M | 988,468 | 31.5% |
| Annexon Inc(ANNX) | COM | 03589W102 | $104.1M | 3,442,122 | 12.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $92.9M | 327,447 | 11.3% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $85.5M | 1,235,645 | 10.4% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $81.9M | 3,327,262 | 10.0% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $54.3M | 1,422,049 | 6.6% |
| Avita Therapeutics Inc(RCEL) | COM | 05380C102 | $44.8M | 1,779,586 | 5.4% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $29.5M | 1,989,200 | 3.6% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $18.4M | 3,514,100 | 2.2% |
| Cytosorbents Corp(CTSO) | COM NEW | 23283X206 | $16.8M | 2,101,131 | 2.0% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $15.4M | 407,400 | 1.9% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $15.0M | 1,386,584 | 1.8% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $504.8K | 12,629,737 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $325.8K | 23,075,807 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $275.1K | 3,234,934 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $252.8K | 3,425,455 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $245.0K | 4,774,918 | 0.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $209.6K | 6,353,094 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $197.6K | 2,425,560 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $181.4K | 2,869,962 | 0.0% |
| OAK STR Health Inc(OSH3EUR) | COM | 67181A107 | $141.7K | 2,652,411 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $99.2K | 8,311,633 | 0.0% |
| 1Life Healthcare Inc | COM | 68269G107 | $94.9K | 3,344,694 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $90.5K | 2,593,570 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $89.9K | 6,938,870 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $88.3K | 2,732,660 | 0.0% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $87.4K | 1,743,048 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $85.4K | 2,549,506 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $79.5K | 2,432,408 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $76.8K | 3,391,757 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $76.7K | 3,330,999 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $74.0K | 2,404,974 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $71.9K | 2,336,357 | 0.0% |
| Cigna Corp New(CI) | COM | 125523100 | $67.2K | 396,693 | 0.0% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $66.9K | 4,713,600 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $64.7K | 1,501,945 | 0.0% |
| Allovir Inc | COM | 019818103 | $64.2K | 2,333,390 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $64.0K | 459,609 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $61.3K | 2,228,166 | 0.0% |
| Tcr2 Therapeutics Inc | COM | 87808K106 | $56.8K | 2,793,288 | 0.0% |
| Aprea Therapeutics Inc | COM | 03836J102 | $54.6K | 2,268,718 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $51.3K | 2,900,889 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $51.3K | 1,101,600 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $50.1K | 4,172,686 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $41.6K | 1,128,827 | 0.0% |
| Axonics Modulation Technolog(AXNX*) | COM | 05465P101 | $37.8K | 741,129 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $37.7K | 10,477,879 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $35.6K | 2,548,168 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $34.4K | 83,412 | 0.0% |
| Amedisys Inc(AMED) | COM | 023436108 | $33.1K | 140,180 | 0.0% |